Editor’s note: Updated times and day for on-track action. The 2026 NASCAR Cup Series season will kick off in exhibition fashion as 23 drivers will battle at Bowman Gray Stadium on Wednesday, Feb. 4 (6 ...

Modern businesses increasingly rely on AI tools for content creation, data analysis, image generation, and customer communication. However, maintaining separate subscriptions for each specialized ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now ...

NASCAR will return in 2026 to its original "Chase" format, a 10-race postseason that will feature 16 drivers vying for the title with consistency playing more of a role than in recent years. Instead ...

NASCAR will return to a 10-race "Chase" postseason format for the Cup Series in 2026. The new system will feature 16 drivers competing for the championship based on total points, not elimination ...

After years of frustration from drivers, fans and many in the garage, NASCAR announced its new playoff format on Monday afternoon that will be implemented beginning in the 2026 season. The new NASCAR ...

WITH CHAIR SHANNON O’BRIEN, MIKE ERIKA. OVER THE PAST YEAR, DOCTORS, PARENTS AND YOUNG PEOPLE HAVE TOLD US ABOUT THE NEGATIVE IMPACTS OF HIGH THC MARIJUANA. THEY SAY IT’S CAUSING PROBLEMS FROM ...

Master cloud organization with this cloud storage guide. Learn how to manage multiple cloud storage accounts efficiently and apply best practices for secure, organized data management. Pixabay, ...

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS). The research, published in the journal Environmental International, discovered that ...

Researchers have uncovered shared genetic pathways that link multiple psychiatric disorders. These new findings have the potential to change the way psychiatric disorders are diagnosed and treated, ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...